AUGUSTA — A new Maine law sets a licensing fee for manufacturers of opioids doing business in the state as part of an effort to hold the companies accountable for opioid use disorder.
Senate President Troy Jackson, a Democrat, proposed the law change, and it became law without the signature of Democratic Gov. Janet Mills over the weekend. The law change allows Maine to collect information from the opioid manufacturers, and the state will use funds from the fees collected to help pay for treatment and recovery programs.
The licensing fee is $55,000. The law also includes a product registration fee of $250,000 that applies to the largest of the opioid manufacturers that sell two million or more doses in the state.
The law officially takes effect 90 days after the Maine Legislature adjourns in April. Jackson said the law change is “about holding companies accountable and making sure they’re the ones paying for treatment and recovery programs.”
Send questions/comments to the editors.
-
BusinessNew Balance to start producing face masks to help prevent spread of coronavirus
-
Business
Maine gas prices fall below $2 per gallon as more motorists stay at home
-
Local & State
Blue Hill man dies in car crash
-
Varsity Maine
Spring coaches appreciate opportunity to touch base with their players
-
Business
Maine construction industry slows down but keeps working
Success. Please wait for the page to reload. If the page does not reload within 5 seconds, please refresh the page.
Enter your email and password to access comments.
Hi {SUB NAME}, to comment on stories you must . This profile is in addition to your subscription and website login.
Already have one? .
Invalid username/password.
Please check your email to confirm and complete your registration.
Only subscribers are eligible to post comments. Please subscribe or login to participate in the conversation. Here’s why.
Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.